Literature DB >> 9171470

Hyperbaric oxygen in chronic cluster headaches: influence on serotonergic pathways.

F Di Sabato1, M Rocco, P Martelletti, M Giacovazzo.   

Abstract

A controlled study was done with the aim of assessing the efficacy of hyperbaric oxygen (HBO2) in cluster headache and of studying the possible influence of this therapeutic approach on serotonergic pathways. Fourteen patients, aged between 26 and 56 yr, suffering from the chronic form of cluster headache were treated with HBO2 (n = 10) or environmental air (placebo) ( n = 4) during the 15 sessions of exposure (lasting 30 min each) in the hyperbaric chamber. The influence of this procedure on serotonergic pathways of pain was monitored by means of study of serotonin binding to mononuclear cells before and after the treatment for both subgroups. All of the treated 14 chronic cluster headache patients completed the study. In the subgroup treated with the placebo, no particular modifications on the number of attacks and of analgesic consumption as well as no change in the specific binding curve of serotonin to mononuclear cells were observed, whereas in the subgroup treated with HBO2 the clinical effectiveness and the appearance of plateau in the binding curves indicated that the oxygen therapy could act through serotonergic pathways.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9171470

Source DB:  PubMed          Journal:  Undersea Hyperb Med        ISSN: 1066-2936            Impact factor:   0.698


  9 in total

Review 1.  Inflammatory mechanisms in cervicogenic headache: an integrative view.

Authors:  Paolo Martelletti
Journal:  Curr Pain Headache Rep       Date:  2002-08

2.  The acute antinociceptive effect of hyperbaric oxygen is not accompanied by an increase in markers of oxidative stress.

Authors:  Shulin Liu; Donald Y Shirachi; Raymond M Quock
Journal:  Life Sci       Date:  2014-01-10       Impact factor: 5.037

Review 3.  Cervicogenic headache: practical approaches to therapy.

Authors:  Paolo Martelletti; Hans van Suijlekom
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  [Hyper- or normobaric oxygen therapy to treat migraine and cluster headache pain. Cochrane review].

Authors:  A Schnabel; M Bennet; F Schuster; N Roewer; P Kranke
Journal:  Schmerz       Date:  2008-04       Impact factor: 1.107

5.  Hyperbaric oxygen therapy can diminish fibromyalgia syndrome--prospective clinical trial.

Authors:  Shai Efrati; Haim Golan; Yair Bechor; Yifat Faran; Shir Daphna-Tekoah; Gal Sekler; Gregori Fishlev; Jacob N Ablin; Jacob Bergan; Olga Volkov; Mony Friedman; Eshel Ben-Jacob; Dan Buskila
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

6.  Hyperbaric oxygen attenuates neuropathic pain and reverses inflammatory signaling likely via the Kindlin-1/Wnt-10a signaling pathway in the chronic pain injury model in rats.

Authors:  Baisong Zhao; Yongying Pan; Haiping Xu; Xingrong Song
Journal:  J Headache Pain       Date:  2017-01-05       Impact factor: 7.277

7.  The NO-cGMP-PKG signal transduction pathway is involved in the analgesic effect of early hyperbaric oxygen treatment of neuropathic pain.

Authors:  Yuanyuan Ding; Peng Yao; Tao Hong; Zhenkai Han; Baisong Zhao; Weimin Chen
Journal:  J Headache Pain       Date:  2017-05-03       Impact factor: 7.277

Review 8.  Hyperbaric oxygen therapy in chronic pain management.

Authors:  Senol Yildiz; Gunalp Uzun; M Zeki Kiralp
Journal:  Curr Pain Headache Rep       Date:  2006-04

Review 9.  Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache.

Authors:  Michael H Bennett; Christopher French; Alexander Schnabel; Jason Wasiak; Peter Kranke; Stephanie Weibel
Journal:  Cochrane Database Syst Rev       Date:  2015-12-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.